D. Snook

发表

Direct technetium-99m labeling of three anticancer monoclonal antibodies: stability, pharmacokinetics and imaging.

A. Maraveyas, C. Gooden, D. Snook, 1995, Journal of Nuclear Medicine.

A. Maraveyas, C. Meares, D. Snook, 1974, British Journal of Cancer.

Intraperitoneal yttrium-90-labeled monoclonal antibody in ovarian cancer.

D. Snook, J. Stewart, G. Sivolapenko, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intraperitoneal radioimmunotherapy for ovarian cancer: pharmacokinetics, toxicity, and efficacy of I-131 labeled monoclonal antibodies.

D. Snook, A. Epenetos, A. Munro, 1989, International journal of radiation oncology, biology, physics.

Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy.

C. Meares, M. Mccall, C. Gooden, 1992, Cancer research.

Tumour localisation with a radioactively labelled reshaped human monoclonal antibody.

A. Bamias, C. Meares, R. A. Badley, 1991, British Journal of Cancer.

Antibody-guided irradiation of malignant pleural and pericardial effusions.

S. Stewart, J. Taylor‐Papadimitriou, T. Krausz, 1986, British journal of cancer.

Antibody-guided irradiation of malignant lesions: three cases illustrating a new method of treatment. A report from the Hammersmith Oncology Group and the Imperial Cancer Research Fund.

J. Taylor‐Papadimitriou, J. S. Orr, T. Krausz, 1984, The Lancet.

Intraperitoneal radioimmunotherapy for ovarian cancer

M. Sullivan, D. Snook, A. Epenetos, 1989 .

Intraperitoneally administered 90Y-labelled monoclonal antibodies as a third line of treatment in ovarian cancer. A phase 1-2 trial: problems encountered and possible solutions.

W. Mason, D. Snook, A. Epenetos, 1990, The British journal of cancer. Supplement.

Antibody-guided localization of intraperitoneal tumors following intraperitoneal or intravenous antibody administration.

A. Busza, D. Snook, A. Epenetos, 1987, Cancer research.

Enhancement by gamma-interferon of in vivo tumor radiolocalization by a monoclonal antibody against HLA-DR antigen.

F. Balkwill, D. Snook, A. Epenetos, 1986, Cancer research.

TUMOUR IMAGING USING AN IMPROVED METHOD OF DTPA-COUPLED MONOCLONAL ANTIBODIES RADIOLABELLED WITH METALLIC RADIONUCLIDES

D. Snook, J. P. Lavender, A. Epenetos, 1984, The Lancet.

INDIUM-111 LABELLED MONOCLONAL ANTIBODY TO PLACENTAL ALKALINE PHOSPHATASE IN THE DETECTION OF NEOPLASMS OF TESTIS, OVARY, AND CERVIX

W. Bodmer, R. Oliver, D. Snook, 1985, The Lancet.

Conjugation of monoclonal antibodies to a synthetic peptide substrate for protein kinase: a method for labelling antibodies with 32P.

P. Parker, B. Foxwell, W. Jeffery, 1988, British Journal of Cancer.

Preparation and in vivo study of 124I-labelled monoclonal antibody H17E2 in a human tumour xenograft model. A prelude to positron emission tomography (PET).

D. Snook, A. Epenetos, H. Sharma, 1990, The British journal of cancer. Supplement.

Macrocyclic chelates of radiometals for diagnosis and therapy.

S. Denardo, D. Kukis, C. Meares, 1990, The British journal of cancer. Supplement.

Antibody guided targeting of non-small cell lung cancer using 111In-labeled HMFG1 F(ab')2 fragments.

J. Taylor‐Papadimitriou, H. Kalofonos, D. Snook, 1988, Cancer research.

Antibody guided diagnosis and therapy of brain gliomas using radiolabeled monoclonal antibodies against epidermal growth factor receptor and placental alkaline phosphatase.

H. Kalofonos, D. Snook, A. Epenetos, 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Intraperitoneal 131I‐ and 90‐labelled monoclonal antibodies for ovarian cancer: Pharmacokinetics and normal tissue dosimetry

D. Snook, M. Myers, J. Stewart, 1988 .

Preparation and use of DTPA-coupled antitumor antibodies radiolabeled with yttrium-90.

S. Stewart, D. Hnatowich, D. Snook, 1988, Targeted diagnosis and therapy.

Pharmacokinetics and toxicity of an yttrium-90-CITC-DTPA-HMFG1 radioimmunoconjugate for intraperitoneal radioimmunotherapy of ovarian cancer.

A. Maraveyas, C. Meares, D. Snook, 1994, Cancer.

Anti-chelate antibodies after intraperitoneal yttrium-90-labeled monoclonal antibody immunoconjugates for ovarian cancer therapy.

A. Maraveyas, C. Gooden, D. Snook, 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Imaging of tumor in patients with indium-111-labeled biotin and streptavidin-conjugated antibodies: preliminary communication.

H. Kalofonos, M. Rusckowski, D. Hnatowich, 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

High dose chemotherapy with autologous bone marrow rescue in small cell lung cancer.

C. Wilson, S. Stewart, D. Snook, 1988, In vivo.

Targeting of tumours with murine and reshaped human monoclonal antibodies against placental alkaline phosphatase: immunolocalisation, pharmacokinetics and immune response.

H. Kalofonos, D. Snook, A. Epenetos, 1994, European journal of cancer.

Intracavitary use of two radiolabeled tumor-associated monoclonal antibodies.

J. Taylor‐Papadimitriou, D. Snook, P. Papakostas, 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Imaging thrombus with radiolabelled monoclonal antibody to platelets.

N. Hogg, D. Snook, A. Epenetos, 1986, British medical journal.

PROSPECTS FOR ANTIBODY-TARGETED RADIOTHERAPY OF CANCER

T. Wheldon, M. Slevin, J. Shepherd, 1986, The Lancet.

Limitations of radiolabeled monoclonal antibodies for localization of human neoplasms.

J. Taylor‐Papadimitriou, D. Snook, A. Epenetos, 1986, Cancer research.

90Y-labeled antibody uptake by human tumor xenografts and the effect of systemic administration of EDTA.

D. Snook, A. Epenetos, G. Rowlinson‐Busza, 1994, International journal of radiation oncology, biology, physics.

Advantages of the operating microscope in lumbar spine surgery.

J. McCulloch, D. Snook, C. Kruse, 2002, Instructional course lectures.

Evaluation of pulmonary alveolar epithelial integrity by the detection of restriction to diffusion of hydrophilic solutes of different molecular sizes.

M J Myers, A M Peters, D. Snook, 2001, Clinical science.

Immunolocalisation of testicular tumours using radiolabelled monoclonal antibody to placental alkaline phosphatase.

H. Kalofonos, A. Bamias, D. Snook, 1990, The Journal of nuclear medicine and allied sciences.

Technetium-99m-labeled antibodies

C. Gooden, D. Snook, A. Epenetos, 2009, Cell Biophysics.

Quantitative measurement of monoclonal antibody distribution and blood flow using positron emission tomography and 124iodine in patients with breast cancer

T Jones, A A Lammertsma, I. A. Watson, 1991, International journal of cancer.

Use of 123-I Radiolabelled F(AB’)2 Fragments of Anti-CEA Monoclonal Antibody for the Detection of Primary and Metastatic Gastrointestinal Carcinomas

H. Kalofonos, A. Bamias, C. Wood, 1991 .

Intraperitoneal radioimmunotherapy for ovarian cancer

D. Snook, A. Epenetos, J. Stewart, 1990, British Journal of Obstetrics and Gynaecology.

Radiolocalisation of an anti-CEA Monoclonal Antibody (FO23C5) and its Fragments in a Colon Carcinoma Xenograft Model

G. Paganelli, D. Snook, A. Epenetos, 1988, The International journal of biological markers.

Antibody-guided irradiation of malignant pleural and pericardial effusions.

S. Stewart, J. Taylor‐Papadimitriou, T. Krausz, 1986, British Journal of Cancer.